Article
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells
20 Nov 2023
Abstract excerpt
Quiescent human hematopoietic stem cells (HSC) are ideal targets for gene therapy applications due to their preserved stemness and repopulation capacities; however, they have not been exploited extensively because of their resistance to genetic manipulation. We report here the development of a lentiviral transduction protocol that overcomes this resistance in long-term repopulating quiescent HSC, allowing their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
